Andreas Kogelnik, MD, PhD, is director of the Open Medicine Institute - a community-centered precision-medicine organization. He received his MD from Emory University School of Medicine and his PhD in Bioengineering from the Georgia Institute of Technology. He completed a residency in Internal Medicine and a Fellowship in Infectious Diseases at Stanford University.

After eight years at Stanford as an NIH- and HP-funded physician-scientist working at the intersection of genomics, microbiology / immunology, and bioinformatics with Dr. Ellen Jo Baron, Dr. Stanley Falkow, and Dr. Atul Butte, he left Stanford to found the Open Medicine Institute (OMI) in 2011. At OMI, Andreas has successfully driven forward a new collaborative model for precision medicine and patient-centric clinical research networks by harnessing information and biotechnology in a clinical multi-omics approach. At OMI, -omic technologies and IT tools such as OpenMedNet intersect to bring together physicians and patients, pharma, diagnostic companies, government, and foundations. OMI is at the forefront of applying microbiome, metabolome, and other -omic measurements to clinical outcomes.